KPMG: Tailwinds and Headwinds for Payers in 2024
A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers' tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.
A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers' tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Over the next 18 to 24 months, Humana will exit the Employer Group Commercial Medical Products business, which includes fully insured plans, self-funded plans and Federal Employee Health Benefit plans. The decision represents Humana's move to double-down on its Medicare Advantage business, one expert said.
As the healthcare industry prepares for a possible recession, Ash Shehata of KPMG expects to see more use of technology, targeted investments and an impact on consumers' wallets.
The four companies are collaborating under a program that stems from a law that Congress passed in 2013 to develop an electronic pharmaceutical tracking system.
“The complaints about incorporating technology into clinical workflows are fairly common and have many doctors and others involved with care delivery dissatisfied with electronic health records and other tools,” said Todd Ellis, principal at KPMG.